Global epidemiology and burden of interstitial lung disease
Authors:
Top Cited Papers
- 17 July 2025
- journal article
- review article
- Published by Elsevier in The Lancet Respiratory Medicine
- Vol. 13 (8) , 739-755
Abstract
No abstract availableKeywords
Funding Information
- Università degli Studi di Padova
This publication has 119 references indexed in Scilit:
- Evaluation of Pulmonary Fibrosis Outcomes by Race and Ethnicity in US AdultsJAMA Network Open, 2023
- The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness studyThe European Journal of Health Economics, 2022
- Mortality Trends of Idiopathic Pulmonary Fibrosis in the United States From 2004 Through 2017Chest, 2021
- Economic Burden and Management of Systemic Sclerosis-Associated Interstitial Lung Disease in 8 European Countries: The BUILDup Delphi Consensus StudyAdvances in Therapy, 2020
- Hospital-Based Resource Use and Costs Among Patients With Idiopathic Pulmonary Fibrosis Enrolled in the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) RegistryChest, 2020
- Costs of Workplace Productivity Loss in Patients With Fibrotic Interstitial Lung DiseaseChest, 2019
- The Lung in Rheumatoid ArthritisArthritis & Rheumatology, 2018
- Incidence, Prevalence, and Survival of Patients with Idiopathic Pulmonary Fibrosis in the UKAdvances in Therapy, 2018
- Interstitial Lung Disease in the ElderlyChest, 2017
- Pulmonary involvement in systemic sclerosis: Associations with genetic, serologic, sociodemographic, and behavioral factorsArthritis Care & Research, 2007